ADMA Biologics, Inc.
ADMA
$22.33
$0.602.76%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
1/20/2025
-
MarketBeat
4/25/2025
-
MarketBeat
4/24/2025
-
Zacks Investment Research
4/24/2025
-
Insider Monkey
4/23/2025
-
MarketBeat
4/23/2025
-
Insider Monkey
4/23/2025
-
Zacks Investment Research
4/23/2025
-
Ticker Report
4/23/2025
-
MarketBeat
4/23/2025
-
Ticker Report
4/23/2025
-
MarketBeat
4/22/2025
-
Stock Options Channel
4/22/2025
-
Insider Monkey
4/21/2025
-
Zolmax
4/21/2025
-
Ticker Report
4/20/2025
-
MarketBeat
4/20/2025
-
Ticker Report
4/19/2025
-
MarketBeat
4/18/2025
-
MarketBeat
4/17/2025
-
Zacks Investment Research
4/17/2025
-
MarketBeat
4/17/2025
-
MarketBeat
4/17/2025
-
Zacks Investment Research
4/17/2025
-
Yahoo! Finance: News
4/17/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Tuesday, March 18, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
201 478 5552
Address
465 State Route 17
Ramsey, NJ 07446
Ramsey, NJ 07446
Country
Year Founded
Business Description
Sector
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the...
more